Annual CFI
-$1.80 M
-$209.00 K-13.14%
December 31, 2023
Summary
- As of February 12, 2025, HBIO annual cash flow from investing activities is -$1.80 million, with the most recent change of -$209.00 thousand (-13.14%) on December 31, 2023.
- During the last 3 years, HBIO annual CFI has fallen by -$397.00 thousand (-28.32%).
- HBIO annual CFI is now -1152.05% below its all-time high of $171.00 thousand, reached on December 31, 2013.
Performance
HBIO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$1.11 M
-$1.57 M-342.58%
September 30, 2024
Summary
- As of February 12, 2025, HBIO quarterly cash flow from investing activities is -$1.11 million, with the most recent change of -$1.57 million (-342.58%) on September 30, 2024.
- Over the past year, HBIO quarterly CFI has dropped by -$710.00 thousand (-177.06%).
- HBIO quarterly CFI is now -187.62% below its all-time high of $1.27 million, reached on September 30, 2013.
Performance
HBIO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$1.94 M
-$710.00 K-57.77%
September 30, 2024
Summary
- As of February 12, 2025, HBIO TTM cash flow from investing activities is -$1.94 million, with the most recent change of -$710.00 thousand (-57.77%) on September 30, 2024.
- Over the past year, HBIO TTM CFI has dropped by -$966.00 thousand (-99.28%).
- HBIO TTM CFI is now -644.66% below its all-time high of $356.00 thousand, reached on March 31, 2014.
Performance
HBIO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
HBIO Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.1% | -177.1% | -99.3% |
| 3 y3 years | -28.3% | -131.5% | -49.0% |
| 5 y5 years | +96.7% | -207.8% | -746.7% |
HBIO Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -33.8% | at low | -342.6% | at low | -133.3% | +16.1% |
| 5 y | 5-year | -685.6% | at low | -342.6% | at low | -746.7% | +16.1% |
| alltime | all time | -1152.0% | +96.7% | -187.6% | +97.9% | -644.7% | +96.4% |
Harvard Bioscience Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.11 M(-342.6%) | -$1.94 M(+57.8%) |
| Jun 2024 | - | $458.00 K(-303.6%) | -$1.23 M(-46.8%) |
| Mar 2024 | - | -$225.00 K(-78.8%) | -$2.31 M(+28.5%) |
| Dec 2023 | -$1.80 M(+13.1%) | -$1.06 M(+164.6%) | -$1.80 M(+84.9%) |
| Sep 2023 | - | -$401.00 K(-35.8%) | -$973.00 K(-4.0%) |
| Jun 2023 | - | -$625.00 K(-317.0%) | -$1.01 M(+22.0%) |
| Mar 2023 | - | $288.00 K(-222.6%) | -$831.00 K(-47.7%) |
| Dec 2022 | -$1.59 M(+18.2%) | -$235.00 K(-46.8%) | -$1.59 M(-7.2%) |
| Sep 2022 | - | -$442.00 K(0.0%) | -$1.71 M(-2.2%) |
| Jun 2022 | - | -$442.00 K(-6.2%) | -$1.75 M(+15.6%) |
| Mar 2022 | - | -$471.00 K(+31.6%) | -$1.51 M(+12.6%) |
| Dec 2021 | -$1.34 M(-4.1%) | -$358.00 K(-25.4%) | -$1.34 M(+3.4%) |
| Sep 2021 | - | -$480.00 K(+133.0%) | -$1.30 M(-6.1%) |
| Jun 2021 | - | -$206.00 K(-31.6%) | -$1.39 M(-5.3%) |
| Mar 2021 | - | -$301.00 K(-4.1%) | -$1.46 M(+4.3%) |
| Dec 2020 | -$1.40 M(+512.2%) | -$314.00 K(-44.3%) | -$1.40 M(-9.2%) |
| Sep 2020 | - | -$564.00 K(+99.3%) | -$1.54 M(+15.1%) |
| Jun 2020 | - | -$283.00 K(+17.4%) | -$1.34 M(+321.7%) |
| Mar 2020 | - | -$241.00 K(-47.1%) | -$318.00 K(+38.9%) |
| Dec 2019 | -$229.00 K(-99.6%) | -$456.00 K(+26.3%) | -$229.00 K(-42.8%) |
| Sep 2019 | - | -$361.00 K(-148.8%) | -$400.00 K(+35.1%) |
| Jun 2019 | - | $740.00 K(-586.8%) | -$296.00 K(-83.2%) |
| Mar 2019 | - | -$152.00 K(-75.8%) | -$1.76 M(-96.7%) |
| Dec 2018 | -$53.80 M(+5766.5%) | -$627.00 K(+144.0%) | -$53.80 M(+0.8%) |
| Sep 2018 | - | -$257.00 K(-64.5%) | -$53.37 M(+0.0%) |
| Jun 2018 | - | -$723.00 K(-98.6%) | -$53.35 M(+0.9%) |
| Mar 2018 | - | -$52.19 M(>+9900.0%) | -$52.88 M(+5666.4%) |
| Dec 2017 | -$917.00 K(+1379.0%) | -$201.00 K(-16.3%) | -$917.00 K(-621.0%) |
| Sep 2017 | - | -$240.00 K(-3.2%) | $176.00 K(-239.7%) |
| Jun 2017 | - | -$248.00 K(+8.8%) | -$126.00 K(+48.2%) |
| Mar 2017 | - | -$228.00 K(-125.6%) | -$85.00 K(+37.1%) |
| Dec 2016 | -$62.00 K(-99.2%) | $892.00 K(-264.6%) | -$62.00 K(-96.2%) |
| Sep 2016 | - | -$542.00 K(+161.8%) | -$1.63 M(-7.1%) |
| Jun 2016 | - | -$207.00 K(+1.0%) | -$1.76 M(-17.5%) |
| Mar 2016 | - | -$205.00 K(-69.9%) | -$2.13 M(-71.6%) |
| Dec 2015 | -$7.52 M(-44.4%) | -$680.00 K(+1.9%) | -$7.52 M(-60.9%) |
| Sep 2015 | - | -$667.00 K(+14.8%) | -$19.21 M(+1.0%) |
| Jun 2015 | - | -$581.00 K(-89.6%) | -$19.02 M(+0.4%) |
| Mar 2015 | - | -$5.59 M(-54.8%) | -$18.94 M(+40.1%) |
| Dec 2014 | -$13.52 M(-8004.7%) | -$12.37 M(+2466.2%) | -$13.52 M(+741.7%) |
| Sep 2014 | - | -$482.00 K(-3.0%) | -$1.61 M(-1215.3%) |
| Jun 2014 | - | -$497.00 K(+194.1%) | $144.00 K(-59.6%) |
| Mar 2014 | - | -$169.00 K(-63.1%) | $356.00 K(+108.2%) |
| Dec 2013 | $171.00 K(-103.7%) | -$458.00 K(-136.1%) | $171.00 K(-347.8%) |
| Sep 2013 | - | $1.27 M(-544.9%) | -$69.00 K(-96.3%) |
| Jun 2013 | - | -$285.00 K(-19.5%) | -$1.84 M(-21.8%) |
| Mar 2013 | - | -$354.00 K(-49.3%) | -$2.36 M(-49.6%) |
| Dec 2012 | -$4.68 M | -$698.00 K(+37.4%) | -$4.68 M(-1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | -$508.00 K(-36.3%) | -$4.73 M(-51.2%) |
| Jun 2012 | - | -$798.00 K(-70.1%) | -$9.68 M(+3.9%) |
| Mar 2012 | - | -$2.67 M(+257.2%) | -$9.32 M(+29.5%) |
| Dec 2011 | -$7.20 M(-13.8%) | -$748.00 K(-86.3%) | -$7.20 M(-6.7%) |
| Sep 2011 | - | -$5.46 M(+1147.0%) | -$7.71 M(+9.0%) |
| Jun 2011 | - | -$438.00 K(-20.4%) | -$7.08 M(-15.4%) |
| Mar 2011 | - | -$550.00 K(-56.4%) | -$8.37 M(+0.3%) |
| Dec 2010 | -$8.35 M(-62.6%) | -$1.26 M(-73.9%) | -$8.35 M(-46.6%) |
| Sep 2010 | - | -$4.83 M(+179.2%) | -$15.62 M(-34.6%) |
| Jun 2010 | - | -$1.73 M(+227.5%) | -$23.87 M(+6.0%) |
| Mar 2010 | - | -$528.00 K(-93.8%) | -$22.52 M(+1.0%) |
| Dec 2009 | -$22.30 M(+748.6%) | -$8.53 M(-34.8%) | -$22.30 M(+56.9%) |
| Sep 2009 | - | -$13.08 M(+3407.8%) | -$14.21 M(+623.9%) |
| Jun 2009 | - | -$373.00 K(+20.3%) | -$1.96 M(-12.8%) |
| Mar 2009 | - | -$310.00 K(-30.0%) | -$2.25 M(-14.4%) |
| Dec 2008 | -$2.63 M(-59.9%) | -$443.00 K(-47.1%) | -$2.63 M(-64.9%) |
| Sep 2008 | - | -$837.00 K(+26.8%) | -$7.49 M(+6.1%) |
| Jun 2008 | - | -$660.00 K(-4.1%) | -$7.06 M(+5.4%) |
| Mar 2008 | - | -$688.00 K(-87.0%) | -$6.70 M(+2.2%) |
| Dec 2007 | -$6.55 M(+73.3%) | -$5.30 M(+1209.9%) | -$6.55 M(+165.0%) |
| Sep 2007 | - | -$405.00 K(+34.6%) | -$2.47 M(-12.2%) |
| Jun 2007 | - | -$301.00 K(-44.4%) | -$2.82 M(-31.7%) |
| Mar 2007 | - | -$541.00 K(-55.8%) | -$4.12 M(+9.0%) |
| Dec 2006 | -$3.78 M(+251.4%) | -$1.23 M(+63.6%) | -$3.78 M(+44.1%) |
| Sep 2006 | - | -$749.00 K(-53.3%) | -$2.62 M(+20.5%) |
| Jun 2006 | - | -$1.60 M(+694.6%) | -$2.18 M(+134.2%) |
| Mar 2006 | - | -$202.00 K(+201.5%) | -$929.00 K(-13.7%) |
| Dec 2005 | -$1.08 M(-89.7%) | -$67.00 K(-77.8%) | -$1.08 M(-49.8%) |
| Sep 2005 | - | -$302.00 K(-15.6%) | -$2.14 M(-28.3%) |
| Jun 2005 | - | -$358.00 K(+2.6%) | -$2.99 M(-24.4%) |
| Mar 2005 | - | -$349.00 K(-69.2%) | -$3.95 M(-62.1%) |
| Dec 2004 | -$10.42 M(-53.5%) | -$1.13 M(-1.2%) | -$10.42 M(-34.9%) |
| Sep 2004 | - | -$1.15 M(-13.2%) | -$16.00 M(-7.7%) |
| Jun 2004 | - | -$1.32 M(-80.6%) | -$17.34 M(+4.9%) |
| Mar 2004 | - | -$6.81 M(+1.5%) | -$16.54 M(-26.2%) |
| Dec 2003 | -$22.40 M(+81.1%) | -$6.72 M(+169.7%) | -$22.40 M(-13.0%) |
| Sep 2003 | - | -$2.49 M(+379.8%) | -$25.76 M(+4.2%) |
| Jun 2003 | - | -$519.00 K(-95.9%) | -$24.72 M(+0.5%) |
| Mar 2003 | - | -$12.67 M(+25.8%) | -$24.59 M(+98.9%) |
| Dec 2002 | -$12.37 M(-38.7%) | -$10.08 M(+594.9%) | -$12.37 M(+33.7%) |
| Sep 2002 | - | -$1.45 M(+266.2%) | -$9.25 M(+6.3%) |
| Jun 2002 | - | -$396.00 K(-11.0%) | -$8.71 M(-56.9%) |
| Mar 2002 | - | -$445.00 K(-93.6%) | -$20.21 M(+0.2%) |
| Dec 2001 | -$20.18 M(+278.4%) | -$6.96 M(+669.3%) | -$20.18 M(+52.7%) |
| Sep 2001 | - | -$905.00 K(-92.4%) | -$13.21 M(+7.4%) |
| Jun 2001 | - | -$11.89 M(+2773.2%) | -$12.31 M(+2873.2%) |
| Mar 2001 | - | -$414.00 K | -$414.00 K |
| Dec 2000 | -$5.33 M(-37.6%) | - | - |
| Dec 1999 | -$8.55 M | - | - |
FAQ
- What is Harvard Bioscience annual cash flow from investing activities?
- What is the all time high annual CFI for Harvard Bioscience?
- What is Harvard Bioscience annual CFI year-on-year change?
- What is Harvard Bioscience quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Harvard Bioscience?
- What is Harvard Bioscience quarterly CFI year-on-year change?
- What is Harvard Bioscience TTM cash flow from investing activities?
- What is the all time high TTM CFI for Harvard Bioscience?
- What is Harvard Bioscience TTM CFI year-on-year change?
What is Harvard Bioscience annual cash flow from investing activities?
The current annual CFI of HBIO is -$1.80 M
What is the all time high annual CFI for Harvard Bioscience?
Harvard Bioscience all-time high annual cash flow from investing activities is $171.00 K
What is Harvard Bioscience annual CFI year-on-year change?
Over the past year, HBIO annual cash flow from investing activities has changed by -$209.00 K (-13.14%)
What is Harvard Bioscience quarterly cash flow from investing activities?
The current quarterly CFI of HBIO is -$1.11 M
What is the all time high quarterly CFI for Harvard Bioscience?
Harvard Bioscience all-time high quarterly cash flow from investing activities is $1.27 M
What is Harvard Bioscience quarterly CFI year-on-year change?
Over the past year, HBIO quarterly cash flow from investing activities has changed by -$710.00 K (-177.06%)
What is Harvard Bioscience TTM cash flow from investing activities?
The current TTM CFI of HBIO is -$1.94 M
What is the all time high TTM CFI for Harvard Bioscience?
Harvard Bioscience all-time high TTM cash flow from investing activities is $356.00 K
What is Harvard Bioscience TTM CFI year-on-year change?
Over the past year, HBIO TTM cash flow from investing activities has changed by -$966.00 K (-99.28%)